Telomerase activity and the subunit of telomerase in hydatidiform mole and their relationship with the development of postmolar tumor

European Journal of Gynaecological Oncology

Volumn 27, Issue 5, 2006, Pages 473-476

  Wang, F ^a   Huang, H ^a   Kang, X ^a   Chen, B ^a   Li, Y ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Gestational trophoblastic disease; hTERT; hTR; Hydatidiform mole; Telomerase activity

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBUNIT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDATIDIFORM MOLE; PLACENTA VILLUS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TROPHOBLAST; TROPHOBLASTIC TUMOR;

CELL LINE; CELLS, CULTURED; CHORIONIC VILLI; FEMALE; GENETIC MARKERS; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; HYDATIDIFORM MOLE; PLACENTA; PREGNANCY; RIBONUCLEASES; RNA; TELOMERASE; UTERINE NEOPLASMS;

EID: 33751174286     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L. et al.: "Specific association of human telomerase activity with immortal cells and cancer". Science, 1994, 266, 2011.
2. Feng J., Funk W.D., Wang S.S., Weinrich S.L., Avilion A.A., Chiu C.P. et al.: "The RNA component of human telomerase". Science, 1995, 269, 1236.
3. Damm K., Hemmann U., Garin-Chesa P., Hauel N., Kauffmann I., Priepke H. et al.: "A highly selective telomerase inhibitor limiting human cancer cell proliferation". EMBO J., 2001, 20, 6958.
4. Zaffaroni N., Villa R., Pennati M., Folini M.: "Approaches for the inhibition of human telomerase based on the use of peptide nucleic acids and hammerhead ribozymes". Mini Rev. Med. Chem., 2003, 3, 51.
5. Hiyama E., Gollahon L., Kataoka T., Kuroi K., Yokoyama T., Gazdar A.F. et al.: "Telomerase activity in human breast tumors". J. Natl Cancer Inst., 1996, 88, 116.
6. Cheng R.Y., Yuen P.W., Nicholls J.M., Zheng Z., Wei W., Sham J.S. et al.: "Telomerase activation in nasopharyngeal carcinomas". Br. J. Cancer, 1998, 77, 456.
7. Zhang D.K., Ngan H.Y., Cheng R.Y., Cheung A.N., Liu S.S., Tsao S.W.: "Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer". Eur. J. Cancer, 1999, 35, 154.
8. Song H., Yang X., Xiang Y. (eds.): Trophoblastic Tumors Diagnosis & Treatment. China: People's Medical Publishing Press, 2004.
9. Cheng R.Y., Yuen P.W., Nicholls J.M., Zheng Z., Wei W., Sham J.S. et al.: "Telomerase activation in nasopharyngeal carcinomas". Br. J. Cancer, 1998, 77, 456.
10. Bradford M.M.: "A rapid and sensitive method for the quantification of microgram quantities". Anal. Biochem., 1976, 72, 248.
11. McEachern M.J., Krauskopf, Blackburn E.H.: "Telomeres and their control". Annu. Rev. Genet., 2000, 34, 331.
12. Rhyu M.S.: "Telomeres, telomerase and immortality". J. Natl. Cancer Inst., 1995, 87, 884.
13. Reddel R.R., Bryan T.M., Colgin L.M., Perrem K.T., Yeager T.R.: "Alternative lengthening of telomeres in human cells". Radiat. Res., 2001, 155, 194.
14. Takagi S., Kinouchi Y., Hiwatashi N., Chida M., Nagashima F., Takahashi S. et al.: "Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas". Cancer, 1999, 86, 1431.
15. Chen R.J., Chu C.T., Huang S.C., Chow S.N., Hsieh C.Y.: "Telomerase activity in gestational trophoblastic disease and placental tissue from early and late human pregnancies". Hum. Reprod., 2002, 17, 463.
16. Weinrich S.L., Pruzan R., Ma L., Ouellette M., Tesmer V.M., Holt S.E. et al.: "Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT". Nat. Genet., 1997, 17, 498.
17. Kolquist K.A., Ellisen L.W., Counter C.M., Meyerson M., Tan L.K., Weinberg R.A. et al.: "Expression of TERT in early premalignant lesions and a subset of cells in normal tissues". Nat. Genet., 1998, 19, 182.
18. Avilion A.A., Piatyszek M.A., Gupta J., Shay J.W., Bacchetti S., Greider C.W.: "Human telomerase activity in immortal cell lines and tumor tissues". Cancer Res., 1996, 56, 645.
19. Roberts D.J., Mutter G.: "Advances in the molecular biology of gestational trophoblastic disease". J. Reprod. Med., 1994, 39, 201.
20. Hong Z.S., Wu P.C.: "Studies in Trophoblastic Diseases in China". Oxford, Pergamon Press, 1988.
21. Wang F., Kang X., Tan Y., Li Y.: "Preliminary study on c-Ha-ras oncogene mutations in hydatidiform mole tissues". Reprod. Contracept., 2001, 12, 162.
22. Wang F., Kang X., Pang J., Li Y.: "Expression of CD44 Variant 6 in hydatidiform mole and their relationship with development of postmolar tumor". Chinese J. Pract. Gynecol. Obstet., 2004, 20, 223.
23. Sarkar S., Kacinski B.M., Kohorn E.I., Merino M.J., Carter D., Blakemore K.J.: "Demonstration of myc and ras oncogene expression by hybridization in situ in hydatidiform mole and in the BeWo chariocarcinoma cell line". Am. J. Obstet. Gynecol., 1986, 154, 390.
24. Katagiri Y.U., Sleeman J., Fujii H., Herrlich P., Hotta H., Tanaka K. et al.: "CD44 variants but not CD44s cooperate with b1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis". Cancer Res., 1999, 59, 219.
25. Amezcua C.A., Bahador A., Naidu Y.M., Felix JC. TI: "Expression of human telomerase reverse transcriptase, the catalytic subunit of telomerase, is associated with the development of persistent disease in complete hydatidiform moles". Am. J. Obstet. Gynecol., 2001, 184, 14